Apollo Hospitals Enterprise Limited (APOLLOHOSP) — FY26 Annual Report | 1 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
AGM scheduled for August 25, 2026, to approve FY2025-26 financials, declare dividends, and reappoint directors including Dr. Prathap C Reddy as Executive Chairman for two years.
🔄 What Changed
Approved final dividend of ₹10 per share (200% payout) payable by September 10, 2026; reappointed Dr. Prathap C Reddy as Executive Chairman for two years; sought shareholder approval for ₹7,500 million non-convertible debentures issuance; ratified cost auditor remuneration.
🔮 What's Next
Re-appointment of Dr. Prathap C Reddy as Executive Chairman for two years (June 25, 2026–June 24, 2028); expansion plans for 1,000 new beds in FY26-27; continued focus on AI-driven healthcare innovation and digital transformation; strategic consolidation in maternity and fertility care via proposed combination with Cloudnine.
💡 Investor Takeaway
Shareholders should note the proposed final dividend of ₹10 per share (200% payout) is subject to AGM approval, and the re-appointment of Dr. Prathap C Reddy ensures leadership continuity amid strategic transformation, including the Apollo Healthtech demerger and expanded digital health initiatives.

Apollo Hospitals Enterprise Limited announced its 45th Annual General Meeting (AGM) scheduled for August 25, 2026, via video conferencing, to adopt FY 2025-26 financial statements, declare interim and final dividends, and reappoint directors including Dr. Prathap C Reddy as Executive Chairman for two years and Smt. Rama Bijapurkar as Independent Director for a second term. The filing includes resolutions for private placement of non-convertible debentures up to ₹7,500 million, ratification of cost auditor remuneration, and shareholder approval for special resolutions on debenture issuance and auditor remuneration. Dividend details show an interim dividend of ₹10 per share (200% payout) paid on February 27, 2026, and a proposed final dividend of ₹10 per share (200% payout) payable by September 10, 2026, totaling ₹2,875.70 million for the year. Shareholding stands at 28.02% promoter and 71.98% public, with 99.41% dematerialized shares. Governance updates include board composition, committee structures, and compliance with SEBI and Companies Act norms. The filing also covers strategic initiatives like AI-driven healthcare innovation, expansion plans (1,000 new beds in FY26-27), and sustainability efforts including 30% renewable energy usage.

📄 View Original Announcement (PDF)

About Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,16,213.95 Cr P/E: 64.5 ROE: 21.9% ROCE: 20.5%

View full APOLLOHOSP stock details →

📡 Get AI alerts when APOLLOHOSP files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APOLLOHOSP — Free

📊 More APOLLOHOSP filings

See all APOLLOHOSP filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when APOLLOHOSP files new disclosures

Track APOLLOHOSP filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track APOLLOHOSP — Free

Free account · 2 AI queries/day